Please assess the completion status of the following clinical trial:

Trial Title: Evaluation by HR-pQCT of Bone Microarchitecture Changes in Patients With Rheumatoid Arthritis Under Anti-TNF Therapy.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Men from 18 to 65 years old~* Women from 18 years old to menopause~* Patient with a polyarthritis rheumatoid no controlled by the usual treatment (DAS28\>3)~* Patient affiliated or beneficiary of a national insurance system~* Patient with signed consent~Exclusion Criteria:~* Concomitant osseous disease (Paget's disease, osteomalacia...)~* Endocrinopathy defined on biological criteria (Cushing's disease, hyperthyroidism, hypogonadism...)~* Patients under protection of justice~* Refusal consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- patients with anti-TNF therapy (Type: OTHER): patients with rheumatoid polyarthritis inadequately controlled by a conventional treatment, occurring during the first 12 months of initiation of an anti-TNF therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).